table of content
1 Introduction to Research & Analysis Reports
1.1 Companion Diagnostics (CDx) Development Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Companion Diagnostics (CDx) Development Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Companion Diagnostics (CDx) Development Services Overall Market Size
2.1 Global Companion Diagnostics (CDx) Development Services Market Size: 2022 VS 2029
2.2 Global Companion Diagnostics (CDx) Development Services Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Companion Diagnostics (CDx) Development Services Players in Global Market
3.2 Top Global Companion Diagnostics (CDx) Development Services Companies Ranked by Revenue
3.3 Global Companion Diagnostics (CDx) Development Services Revenue by Companies
3.4 Top 3 and Top 5 Companion Diagnostics (CDx) Development Services Companies in Global Market, by Revenue in 2022
3.5 Global Companies Companion Diagnostics (CDx) Development Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Companion Diagnostics (CDx) Development Services Players in Global Market
3.6.1 List of Global Tier 1 Companion Diagnostics (CDx) Development Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Companion Diagnostics (CDx) Development Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Companion Diagnostics (CDx) Development Services Market Size Markets, 2022 & 2029
4.1.2 Feasibility Studies
4.1.3 Assay Development
4.1.4 Analytical Validation
4.1.5 Clinical Validation
4.1.6 Others
4.2 By Type - Global Companion Diagnostics (CDx) Development Services Revenue & Forecasts
4.2.1 By Type - Global Companion Diagnostics (CDx) Development Services Revenue, 2018-2023
4.2.2 By Type - Global Companion Diagnostics (CDx) Development Services Revenue, 2024-2029
4.2.3 By Type - Global Companion Diagnostics (CDx) Development Services Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Companion Diagnostics (CDx) Development Services Market Size, 2022 & 2029
5.1.2 Infectious Diseases
5.1.3 Neurological Disorders
5.2 By Application - Global Companion Diagnostics (CDx) Development Services Revenue & Forecasts
5.2.1 By Application - Global Companion Diagnostics (CDx) Development Services Revenue, 2018-2023
5.2.2 By Application - Global Companion Diagnostics (CDx) Development Services Revenue, 2024-2029
5.2.3 By Application - Global Companion Diagnostics (CDx) Development Services Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Companion Diagnostics (CDx) Development Services Market Size, 2022 & 2029
6.2 By Region - Global Companion Diagnostics (CDx) Development Services Revenue & Forecasts
6.2.1 By Region - Global Companion Diagnostics (CDx) Development Services Revenue, 2018-2023
6.2.2 By Region - Global Companion Diagnostics (CDx) Development Services Revenue, 2024-2029
6.2.3 By Region - Global Companion Diagnostics (CDx) Development Services Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Companion Diagnostics (CDx) Development Services Revenue, 2018-2029
6.3.2 US Companion Diagnostics (CDx) Development Services Market Size, 2018-2029
6.3.3 Canada Companion Diagnostics (CDx) Development Services Market Size, 2018-2029
6.3.4 Mexico Companion Diagnostics (CDx) Development Services Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Companion Diagnostics (CDx) Development Services Revenue, 2018-2029
6.4.2 Germany Companion Diagnostics (CDx) Development Services Market Size, 2018-2029
6.4.3 France Companion Diagnostics (CDx) Development Services Market Size, 2018-2029
6.4.4 U.K. Companion Diagnostics (CDx) Development Services Market Size, 2018-2029
6.4.5 Italy Companion Diagnostics (CDx) Development Services Market Size, 2018-2029
6.4.6 Russia Companion Diagnostics (CDx) Development Services Market Size, 2018-2029
6.4.7 Nordic Countries Companion Diagnostics (CDx) Development Services Market Size, 2018-2029
6.4.8 Benelux Companion Diagnostics (CDx) Development Services Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Companion Diagnostics (CDx) Development Services Revenue, 2018-2029
6.5.2 China Companion Diagnostics (CDx) Development Services Market Size, 2018-2029
6.5.3 Japan Companion Diagnostics (CDx) Development Services Market Size, 2018-2029
6.5.4 South Korea Companion Diagnostics (CDx) Development Services Market Size, 2018-2029
6.5.5 Southeast Asia Companion Diagnostics (CDx) Development Services Market Size, 2018-2029
6.5.6 India Companion Diagnostics (CDx) Development Services Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Companion Diagnostics (CDx) Development Services Revenue, 2018-2029
6.6.2 Brazil Companion Diagnostics (CDx) Development Services Market Size, 2018-2029
6.6.3 Argentina Companion Diagnostics (CDx) Development Services Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Companion Diagnostics (CDx) Development Services Revenue, 2018-2029
6.7.2 Turkey Companion Diagnostics (CDx) Development Services Market Size, 2018-2029
6.7.3 Israel Companion Diagnostics (CDx) Development Services Market Size, 2018-2029
6.7.4 Saudi Arabia Companion Diagnostics (CDx) Development Services Market Size, 2018-2029
6.7.5 UAE Companion Diagnostics (CDx) Development Services Market Size, 2018-2029
7 Companion Diagnostics (CDx) Development Services Companies Profiles
7.1 Geneuity-Clinical Research Services
7.1.1 Geneuity-Clinical Research Services Company Summary
7.1.2 Geneuity-Clinical Research Services Business Overview
7.1.3 Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Major Product Offerings
7.1.4 Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Revenue in Global Market (2018-2023)
7.1.5 Geneuity-Clinical Research Services Key News & Latest Developments
7.2 Interpace Biosciences
7.2.1 Interpace Biosciences Company Summary
7.2.2 Interpace Biosciences Business Overview
7.2.3 Interpace Biosciences Companion Diagnostics (CDx) Development Services Major Product Offerings
7.2.4 Interpace Biosciences Companion Diagnostics (CDx) Development Services Revenue in Global Market (2018-2023)
7.2.5 Interpace Biosciences Key News & Latest Developments
7.3 Labcorp
7.3.1 Labcorp Company Summary
7.3.2 Labcorp Business Overview
7.3.3 Labcorp Companion Diagnostics (CDx) Development Services Major Product Offerings
7.3.4 Labcorp Companion Diagnostics (CDx) Development Services Revenue in Global Market (2018-2023)
7.3.5 Labcorp Key News & Latest Developments
7.4 Quest Diagnostics
7.4.1 Quest Diagnostics Company Summary
7.4.2 Quest Diagnostics Business Overview
7.4.3 Quest Diagnostics Companion Diagnostics (CDx) Development Services Major Product Offerings
7.4.4 Quest Diagnostics Companion Diagnostics (CDx) Development Services Revenue in Global Market (2018-2023)
7.4.5 Quest Diagnostics Key News & Latest Developments
7.5 Q? Solutions
7.5.1 Q? Solutions Company Summary
7.5.2 Q? Solutions Business Overview
7.5.3 Q? Solutions Companion Diagnostics (CDx) Development Services Major Product Offerings
7.5.4 Q? Solutions Companion Diagnostics (CDx) Development Services Revenue in Global Market (2018-2023)
7.5.5 Q? Solutions Key News & Latest Developments
7.6 ResearchDx
7.6.1 ResearchDx Company Summary
7.6.2 ResearchDx Business Overview
7.6.3 ResearchDx Companion Diagnostics (CDx) Development Services Major Product Offerings
7.6.4 ResearchDx Companion Diagnostics (CDx) Development Services Revenue in Global Market (2018-2023)
7.6.5 ResearchDx Key News & Latest Developments
7.7 Almac Diagnostic Services
7.7.1 Almac Diagnostic Services Company Summary
7.7.2 Almac Diagnostic Services Business Overview
7.7.3 Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Major Product Offerings
7.7.4 Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Revenue in Global Market (2018-2023)
7.7.5 Almac Diagnostic Services Key News & Latest Developments
7.8 Biocartis
7.8.1 Biocartis Company Summary
7.8.2 Biocartis Business Overview
7.8.3 Biocartis Companion Diagnostics (CDx) Development Services Major Product Offerings
7.8.4 Biocartis Companion Diagnostics (CDx) Development Services Revenue in Global Market (2018-2023)
7.8.5 Biocartis Key News & Latest Developments
7.9 Cerba Research
7.9.1 Cerba Research Company Summary
7.9.2 Cerba Research Business Overview
7.9.3 Cerba Research Companion Diagnostics (CDx) Development Services Major Product Offerings
7.9.4 Cerba Research Companion Diagnostics (CDx) Development Services Revenue in Global Market (2018-2023)
7.9.5 Cerba Research Key News & Latest Developments
7.10 Eurofins Scientific
7.10.1 Eurofins Scientific Company Summary
7.10.2 Eurofins Scientific Business Overview
7.10.3 Eurofins Scientific Companion Diagnostics (CDx) Development Services Major Product Offerings
7.10.4 Eurofins Scientific Companion Diagnostics (CDx) Development Services Revenue in Global Market (2018-2023)
7.10.5 Eurofins Scientific Key News & Latest Developments
7.11 MLM Medical Labs
7.11.1 MLM Medical Labs Company Summary
7.11.2 MLM Medical Labs Business Overview
7.11.3 MLM Medical Labs Companion Diagnostics (CDx) Development Services Major Product Offerings
7.11.4 MLM Medical Labs Companion Diagnostics (CDx) Development Services Revenue in Global Market (2018-2023)
7.11.5 MLM Medical Labs Key News & Latest Developments
7.12 Qiagen
7.12.1 Qiagen Company Summary
7.12.2 Qiagen Business Overview
7.12.3 Qiagen Companion Diagnostics (CDx) Development Services Major Product Offerings
7.12.4 Qiagen Companion Diagnostics (CDx) Development Services Revenue in Global Market (2018-2023)
7.12.5 Qiagen Key News & Latest Developments
7.13 BGI Genomics
7.13.1 BGI Genomics Company Summary
7.13.2 BGI Genomics Business Overview
7.13.3 BGI Genomics Companion Diagnostics (CDx) Development Services Major Product Offerings
7.13.4 BGI Genomics Companion Diagnostics (CDx) Development Services Revenue in Global Market (2018-2023)
7.13.5 BGI Genomics Key News & Latest Developments
7.14 MEDx Translational Medicine
7.14.1 MEDx Translational Medicine Company Summary
7.14.2 MEDx Translational Medicine Business Overview
7.14.3 MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Major Product Offerings
7.14.4 MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Revenue in Global Market (2018-2023)
7.14.5 MEDx Translational Medicine Key News & Latest Developments
7.15 Medical Biological Laboratories (MBL)
7.15.1 Medical Biological Laboratories (MBL) Company Summary
7.15.2 Medical Biological Laboratories (MBL) Business Overview
7.15.3 Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Major Product Offerings
7.15.4 Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Revenue in Global Market (2018-2023)
7.15.5 Medical Biological Laboratories (MBL) Key News & Latest Developments
7.16 Novogene
7.16.1 Novogene Company Summary
7.16.2 Novogene Business Overview
7.16.3 Novogene Companion Diagnostics (CDx) Development Services Major Product Offerings
7.16.4 Novogene Companion Diagnostics (CDx) Development Services Revenue in Global Market (2018-2023)
7.16.5 Novogene Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
